Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-9248158-B2
Publication Date
2016-02-02
Expiration Date
Abstract
In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both.
Core Innovation
The invention relates to an herbal supplement comprising a red quebracho extract, an herbal composition comprising a triterpenoid saponin, and an anti-spasmodic agent. The red quebracho extract is provided in an amount between about 0.5% to about 75% by weight of the total supplement, the herbal composition is provided between about 10% to about 90% by weight, and the anti-spasmodic agent is provided between about 2% to about 70% by weight.
The red quebracho extract is described in connection with condensed tannins, including red quebracho species such as Shinopsis (red quebracho). The herbal composition comprising a triterpenoid saponin is associated with herbal sources including Aesculus hippocastanum extract and/or Sapindus/Satindus species extracts, such as Satindus trifoliatus extract. The anti-spasmodic agent is specifically described as peppermint oil in at least one formulation.
A further aspect describes the herbal supplement as comprising a nutraceutically acceptable carrier and being provided in tablet or capsule form. The dosage form is described with dosage amounts for the red quebracho extract, the herbal composition comprising a triterpenoid saponin, and the anti-spasmodic agent, for treating bloating, constipation and/or weight gain in a human subject.
Claims Coverage
The independent claims are directed to an herbal supplement composition and a tablet or capsule dosage form that include a red quebracho extract, a triterpenoid-saponin-containing herbal composition, and an anti-spasmodic agent. Across the independent claims, the coverage includes three main inventive elements: ingredient combination, quantitative ingredient ranges, and a human-treatment formulation for bloating, constipation, and/or weight gain.
Herbal supplement with red quebracho, triterpenoid saponin, and anti-spasmodic agent for human treatment
An herbal supplement comprising a red quebracho extract; an herbal composition comprising a triterpenoid saponin; and an anti-spasmodic agent, wherein the supplement is formulated to reduce bloating, constipation and/or weight gain in a human subject.
Weight-percentage constraints for the combined herbal components
The red quebracho extract is present in an amount between about 0.5% to about 75% by weight of the total supplement, the herbal composition is present in an amount between about 10% to about 90% by weight of the total supplement, and the anti-spasmodic agent is present in an amount between about 2% to about 70% by weight of the total supplement.
Tablet or capsule dosage form with nutraceutically acceptable carrier and dosage amounts
An herbal supplement for treating bloating, constipation and/or weight gain in a human subject, comprising a red quebracho extract; a nutraceutically acceptable carrier; one or more herbal compositions comprising a triterpenoid saponin; and an anti-spasmodic agent, wherein the herbal supplement is in the form of one or more tablets or capsules, and wherein the herbal supplement is in a dosage form that comprises 10 to 1000 mg red quebracho extract, 50-2000 mg herbal composition comprising a triterpenoid saponin, and 10-1000 mg anti-spasmodic agent.
The claim coverage centers on an herbal supplement formulation that combines a red quebracho extract with a triterpenoid saponin-containing herbal composition and an anti-spasmodic agent, including specified quantitative constraints. Both independent claims tie the formulation to reducing bloating, constipation and/or weight gain in a human subject, with one independent claim requiring tablet or capsule dosage form.
Stated Advantages
Reduce bloating in a human subject.
Reduce constipation in a human subject.
Reduce weight gain in a human subject.
Provide a safety profile as assessed in a single-blinded placebo-controlled study.
Documented Applications
Treating bloating, constipation and/or weight gain in a human subject using the herbal supplement composition.
Relief of bloating/gas and constipation outcomes in a brief single-blinded placebo-controlled clinical study.
Assessment of weight change and safety in the same clinical study.
Interested in licensing this patent?